Clinical Trial Update: A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer. [Phase 2]

View source ↗

Summary

A Phase II clinical trial studying QL1706 combined with anti-angiogenesis therapy and chemotherapy in extensive-stage small cell lung cancer is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Zhijie Wang | Conditions: Extensive Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING